Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Account Payables

Amounts the company owes suppliers for goods and services received.

No reported Account Payables figures are available to summarize.

Account Payables history

Currency unavailable · from the balance sheet

No Account Payables data reported for this period type.

Account Payables vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Account Payables for AVLN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
INSMInsmed IncorporatedJun 2026$428.93M USD+479.2%+16.6%20.4%
MNKDMannKind CorporationMar 2026$16.14M USD+220.3%-6.5%2.2%
VCREVicore Pharma Holding ABJun 2026SEK 2.06M SEK——2.2%
GYREGyre Therapeutics, Inc.Mar 2026$265K USD+117.2%+0.5%0.2%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —+220.3%+0.5%2.2%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.